Stay updated on Pembrolizumab in HER2+ Gastric Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HER2+ Gastric Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The Study Details page has expanded the Contacts and Locations section with a comprehensive list of new sites across the United States and other countries. This increases accessibility for potential participants by showing where enrollment is available.
    Difference
    3%
    Check dated 2025-12-19T12:58:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Completed status was added and the previous 'Active, not recruiting' status was removed. The latest update was posted in November 2025, indicating the trial has finished enrollment and data collection.
    Difference
    0.1%
    Check dated 2025-12-12T11:20:41.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The changes consist of adding Revision: v3.3.2 and removing Revision: v3.3.1, which are minor version updates that do not alter core page content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T06:59:20.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added notes explaining that publications are provided voluntarily by study personnel and may be auto-filled from PubMed. Updated the revision to v3.3.1 and removed older wording about PubMed-derived listings.
    Difference
    0.2%
    Check dated 2025-11-21T02:04:08.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The government funding status banner was removed from the page. The rest of the trial details remain unchanged, including the study overview, eligibility criteria, and locations.
    Difference
    0.1%
    Check dated 2025-11-13T22:36:53.000Z thumbnail image
  8. Check
    57 days ago
    Change Detected
    Summary
    The observed changes are limited to metadata such as the page's last update date and results posting information, with no modification to core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T13:44:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HER2+ Gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HER2+ Gastric Clinical Trial page.